Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSHORT: Intensified Short Course Regimen for TBM
NCT05917340Phase 3Not yet recruiting
- Sponsor
- Indian Council of Medical Research
- Start
- Mar 2024
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rifampicin, moxifloxacin, aspirin in tuberculous meningitis (TBM), sponsored by Indian Council of Medical Research. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
rifampicinmoxifloxacinaspirin
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT05917340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05917340.